Patents Assigned to Maret Corporation
  • Patent number: 6335195
    Abstract: The present invention provides methods, improved cell culture medium and kits for promoting hematopoietic and mesenchymal stem and lineage-specific cell proliferation and differentiation by growth in the presence of angiotensinogen, angiotensin I (AI); AI analogues, AI fragments and analogues thereof, angiotensin II (AII), AII analogues, AII fragments or analogues thereof or AII AT2 type 2 receptor agonists, either alone or in combination with other growth factors and cytokines.
    Type: Grant
    Filed: January 23, 1998
    Date of Patent: January 1, 2002
    Assignee: Maret Corporation
    Inventors: Kathleen E. Rodgers, Gere S. DiZerega